Editorial brief continued
goods giant will pa
- The deal expands P&G's health and wellness division, which already includes the supplements brands Metamucil, Align Probiotic, and New Chapter, as well as Oral-B and Vicks.
- Thorne's annual revenue surpassed $500 million in 2025, according to CNBC .
Event:
Primary source published:
Catalayer published: · Modified:
What happened
P&G to acquire supplement brand Thorne for $3.8 billion P&G to acquire supplement brand Thorne for $3.8 billion · Quartz Cris Tolomia Wed, August 5, 2026 at 2:31 AM GMT+9 2 min read PG P&G CEO Shailesh Jejurikar announced Tuesday on CNBC's "Squawk on the Street" that the consumer goods giant will pay $3.8 billion to acquire supplement brand Thorne. P&G will purchase Thorne from L Catterton's Flagship Fund, and the transaction is expected to close later this year, subject to regulatory approvals and customary closing conditions, the company announced . The deal expands P&G's health and wellness division, which already includes the supplements brands Metamucil, Align Probiotic, and New Chapter, as well as Oral-B and Vicks.
Primary evidence
Primary reporting sourced from Quartz (https://finance.yahoo.com/healthcare/articles/p-g-acquire-supplement-brand-173135989.html). All transaction figures, dates, and statements cross-referenced against wire feeds.
Why it matters
As a significant MERGER ACQUISITION development, this event shifts institutional capital allocations across Financials, Corporate Intelligence and directly alters operating assumptions for related benchmarks.
Transmission mechanisms
Market transmission operates through supply chain linkages, cost-of-capital adjustments, and sector re-rating across Financials, Corporate Intelligence, impacting near-term valuation multiples for related benchmarks.
Uncertainties and competing interpretations
Key execution risks include duration delays, regulatory scrutiny across Financials, Corporate Intelligence, and whether secondary price discovery sustains support for related benchmarks amid macro rotation.
What to monitor next
Key upcoming milestones include official regulatory disclosures, next quarterly SEC filings, and volume-weighted institutional accumulation in related benchmarks.
[S1] Quartz Disclosure & Report
Original factual event report published via Quartz (https://finance.yahoo.com/healthcare/articles/p-g-acquire-supplement-brand-173135989.html). Verified factual financial record with zero synthetic quotes.
Track Real-Time Market Intelligence & Corporate Catalysts
Catalayer News transforms corporate filings, earnings disclosures, and market events into deterministic intelligence signals.